Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: CP-751,871|DRUG: Docetaxel
Sponsor: Pfizer